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Background: Primary care physicians struggle to treat chronic noncancer pain while limiting opioid misuse, abuse,
and diversion. The objective of this study was to understand how primary care physicians perceive their decisions
to prescribe opioids in the context of chronic noncancer pain management. This question is important because
interventions, such as decision support tools, must be designed based on a detailed understanding of how
clinicians use information to make care decisions.
Methods: We conducted in-depth qualitative interviews with family medicine and general internal medicine
physicians until reaching saturation in emergent themes. We used a funneling approach to ask a series of questions
about physicians’ general decision making challenges and use of information when considering chronic opioids.
We then used an iterative, open-coding approach to identify and characterize themes in the data.
Results: We interviewed fifteen physicians with diverse clinical experiences, demographics, and practice affiliations.
Physicians said that general decision making challenges in providing pain management included weighing risks
and benefits of opioid therapies and time and resource constraints. Also, some physicians described their active
avoidance of chronic pain treatment due to concerns about opioid risks. In their decision making, physicians
described the importance of objective and consistent information, the importance of identifying “red flags” related
to risks of opioids, the importance of information about physical function as an outcome, and the importance of
information that engenders trust in patients.
Conclusions: This study identified and described primary care physicians’ struggles to deliver high quality care as they
seek and make decisions based on an array of incomplete, conflicting, and often untrusted patient information.
Decision support systems, education, and other interventions that address these challenges may alleviate primary care
physicians’ struggles and improve outcomes for patients with chronic pain and other challenging conditions.
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Health care qualityBackground
Chronic pain imposes a major clinical, social and economic
burden, affecting an estimated 100 million Americans and
costing $600 billion annually in health care and lost worker
productivity [1,2]. Because of the limited number of pain
specialist physicians, primary care clinicians provide much
of the health care systems’ pain care. Primary care phy-
sicians report frustration when caring for patients with* Correspondence: charle@phhp.ufl.edu
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unless otherwise stated.chronic pain, much of which relates to concerns about
opioid misuse, abuse, and diversion [3-8]. Furthermore,
primary care physicians often have minimal training in
pain care [9] and practical time constraints [10,11]. As the
adoption of health information technology proliferates,
well-designed clinical decision support can help primary
care physicians efficiently obtain and use the relevant, ac-
curate, and timely information needed to prescribe opioids
or alternate pain therapies effectively [12-15].
Prior research has examined physicians’ challenges during
encounters involving opioids [3,4,8], patient and physicianhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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physician attitudes toward opioids [19,5,6,8,20]. But, re-
search has not more closely characterized physicians’ use of
information and decision processes when deciding whether
or not to prescribe opioids. This knowledge is needed so in-
formation systems designers, policymakers, and administra-
tors can design usable and useful systems of care. For
example, some U.S.-based clinical guidelines [21,22] recom-
mend that physicians access and use specific information,
such as opioid risk assessment screeners [23,24], urine drug
screening, standardized pain scales, and prescription drug
monitoring databases. However, evidence suggests physi-
cians do not widely use these tools [25-28]. As is often the
case with systems that suffer from poor adoption, physi-
cian’s failure to use guideline-recommended information
may stem from uncertain value of the information as well
as a practical lack of time and resources [10,11,15]. Thus,
there is a need for a detailed understanding of physicians’
information needs and clinical decision making processes.
With this understanding, new systems, such as decision
support tools, may be better designed with the physicians’
unique work needs in mind. Once implemented, such tools
may help clinicians overcome common barriers, such as
lack of information or time constraints, to the delivery of
guideline-based chronic opioid and chronic noncancer pain
management.
The objective of this study was to understand
how primary care physicians perceive their decisions to
prescribe opioids in the context of chronic noncancer
pain management. As described above, this is important
because systems interventions, such as decision support
tools, must be designed based on an understanding of
how clinicians perceive and make decisions in the con-
text of their daily practice. To answer this question, we
conducted in-depth qualitative interviews with primary
care physicians with varying experience and training
in pain care. Interview techniques are commonly used
in medical decision making research (cite) and are
particularly appropriate for this study because it aims
to inform new decision support tools that physicians
will be likely to adopt and regularly use in their clinical
practice.
Methods
We conducted in-depth qualitative interviews in the
spring of 2013 with family medicine and general internal
medicine physicians practicing in the Gainesville and
Jacksonville areas of north-central Florida. Participation
was voluntary, and all participating physicians gave writ-
ten informed consent to participate. The interviews were
recorded and then transcribed. Identifying information
was removed from the transcripts to preserve physicians’
confidentiality. The study was approved by the University
of Florida Institutional Review Board.To obtain a diverse set of perspectives and fully under-
stand physician decision making, we purposefully re-
cruited from nine practices that spanned rural and urban
settings and that had different racial, ethnic, and socioe-
conomic patient mixes. Furthermore, the practices varied
in organizational structure, including private practices,
United States Veteran’s Health Administration practices,
academic practices located on a university campus, and
academic-affiliated practices that function as independent
community practices. We used emails and phone calls to
invite individuals to participate. To further achieve sample
diversity, we recruited physicians who varied in terms of
age, gender, and experience or training in pain care.
Procedure
We developed a series of semi-structured interview ques-
tions that followed a funneling approach, beginning with
broad questions, such as “tell me about your patients,” and
then moving to increasingly specific questions, such as “tell
me about how you manage patients with chronic non-
cancer pain” and “tell me about the decision process you go
through when you consider whether to prescribe opioids.”
Each question was followed by probing questions to further
clarify physicians’ use of information and use of other
resources and decision strategies. We also included probing
questions that asked about common challenges and infor-
mation needs. To help understand how physicians’ per-
ceived decisions align with guideline recommendations, a
number of the most specific questions asked if and how
physicians use strategies that are recommended by clinical
practice guidelines for chronic opioid therapy, such as risk
assessment and medication tapering or discontinuation [29].
The lead author [CAH] conducted each interview
one-on-one. The lead author is a non-clinician health ser-
vices and health informatics researcher. He had no prior
relationship with any of the participants. Each interview
lasted 30-45 minutes. Interviews were conducted over
approximately two months, with up to four interviews
being conducted in one day. After the first two interviews,
we consulted with a qualitative research methodology
committee that had not been involved in developing the
research objectives. The group included a mix of clinicians
and non-clinicians who reviewed the interview process to
ensure the quality of the questions and consistency of the
process. To increase internal validity of the study, at the
end of each interview day, the interviewer wrote memos
to describe the interview context, document emerging
themes, and to review the interview process. By writing
memos, we were able to identify and protect against po-
tential biases in and preserve consistency of the interviews.
Finally, we continued recruitment and interviews until we
reached saturation. Saturation was judged by the authors
with feedback from the external qualitative research meth-
odology committee [30].
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We chose an open-coding analytic approach to maximally
capture physician attitudes and behaviors. Two authors
[CAH and HQH] independently coded the data to identify
emerging themes on an ongoing basis during the data
collection. The analysts used Nvivo 9 software (QSR
International, Inc.) to store, organize, and iteratively refine
emergent themes in the data [31]. After coding each inter-
view, the analysts wrote reflective memos to describe emer-
ging themes and relationships between themes. The
memos helped ensure consistency in the analytic process
and to reduce the risk of introducing individual biases.
Throughout the process, each analyst periodically reviewed,
merged, and hierarchically organized their themes as they
uncovered similarities and relationships between themes.
Next, the analysts merged their independently derived
codes and arrived at a final set of themes via consensus.
Finally, our team, including a pain psychologist, general in-
ternist, and pain medicine specialist reviewed the emergent
themes and assessed their face and content validity.Results
Our final sample included physicians from one private,
one U.S. Veteran’s Health Administration (VA), and seven
academic-affiliated practices (Table 1). The sample included
nine family medicine and six general internal medicine
physicians and seven men and eight women.Physicians’ information needs and use
Physicians discussed the types of information that are
important to them during clinical encounters for chronicTable 1 Physician participant characteristics
Physician # Sex Specialty Years in practice
1 Female Internal Medicine 21
2 Female Internal Medicine 8
3 Female Family Medicine 9
4 Male Family Medicine 4
5 Female Family Medicine 7
6 Male Internal Medicine 3
7 Female Internal Medicine 14
8 Male Family Medicine 25
9 Male Internal Medicine 7
10 Male Internal Medicine 32
11 Male Family Medicine 11
12 Male Family Medicine 22
13 Female Family Medicine 25
14 Female Family Medicine 18
15 Female Family Medicine 6
Note: Physician # indicates the order in which the interviews were conducted.noncancer pain and how that information affects their
prescribing decisions.
Importance of objective and consistent information
Physicians frequently described their desire for objective
and consistent information about patients’ pain, such
as imaging that shows musculoskeletal pathology. One
physician said: “I also look to see if he’s got legitimate
reasons for pain, ‘cause sometimes patients’ pain is way
out of proportion to objective findings, like radiographic
findings” (Physician 2). Along the same lines, physicians
reported skepticism about the value of patient self-
reported pain (i.e., 0-10 numeric rating scale). Physicians
expressed concern about the inconsistency of self-
reported pain, observed pain behaviors, and exam find-
ings. For example: “Somebody will say, ‘Oh, I have ten
out of [ten] pain”, but they’re sitting there, comfortably.
They’re walking around, totally fine, and you’re like,
‘This is not what I would consider ten out of ten pain”,
(Physician 15). Similarly, another physician expressed
frustration about the legitimacy of pain presentations
that are inconsistent with physical exam:
A lot of people come in with this chronic back pain
that—it should present one way but they’re in pain all
over the place. Their pain is just completely ridiculous,
out of proportion to exam. You just barely touch them.
‘Ahhh!’ Jumping off the table—you know it’s like, all
right, it’s probably not real (Physician 3).
As a consequence of their challenges to assess pain,
physicians frequently described concern about the ap-
propriateness of prescribing opioids.
Importance of identifying “red flags” related to risks of
prescribing opioids
Numerous physicians mentioned the importance of identi-
fying “red flags” that might indicate a patient is medication
seeking, at risk of addiction, or otherwise not a good can-
didate for opioids. Red flags emerge from different infor-
mation, including inconsistencies between subjective and
objective assessments:
I do get nervous if their pain is way out of proportion
to objective findings. We do get outside records. If they
saying that they have very mild degenerate disc, but
there’s 10 out of 10 [pain score] and wanting opiates,
that gives me red flags too. Those are the hardest ones
for us because they’re subjectively in so much pain but
objectively they’re not (Physician 2).
Other potential red flag information that physicians seek
and can trigger concerns about opioid appropriateness
included new patients, patients traveling from another
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apies, patients who request opioid dose increases, psychi-
atric history, drug or alcohol abuse history, suspect
prescription refill history, and unsolicited patient reporting
of pain scores. For example, when asked if he assesses pa-
tients using standardized pain scales, one physician said:
Generally not, scale of one to ten, I do not. That’s a
red flag. Get a new patient and they walk in and, ‘Doc,
my back really hurts, and it’s a nine or ten out of ten.’
[Laughter] Where did they learn that? (Physician 11).
Importance of information about physical function and
outcome goals
Multiple physicians described the importance of pa-
tients’ physical function as the most important outcome.
At times, physicians described their value of physical
function in the same context as their devaluing of pain
scores as subjective and less important outcomes. One
physician explained it succinctly:
I have this little speech I do with everyone that says,
‘The goal of this medicine is not to get rid of all your
pain because if you’re looking for that, I can’t do that
for you. But I can, hopefully, make you more
functional.’ That’s the approach I use (Physician 8).
Another physician went further and described the im-
portant of individualized approaches to identifying and
assessing patients’ functional goals:
Their function might be tailored to, and it probably
should be directed at trying to what would motivate
them to get going. Be it maybe playing with their
grandkids, or walking with their wife, or, so I think the
functional thing should be something. This never
happened, but it should be discussed at that visit
before the opioids are started. What are we trying to
accomplish here? (Physician 10)
Similarly, other physicians described how setting goals
and expectations that are important to the patient can
help them confidently prescribe opioids as well as taper
or discontinue them if patients’ explicit goals, such as
weight loss or function, are not met.
Importance of tacit knowledge and trust in patients
Some physicians went beyond clinical findings and out-
come measures when discussing the information they
use. They described their reliance on harder-to-measure
information, such as their history with and “sense” of
their patients’ need for opioids. One physician explained
“I’ve known some of my patients for over 20 years.
Whether it’s right or wrong, I guess I have a sense ofwhether they’re someone that I feel could or would ap-
propriately use these medications” (Physician 8). These
reports suggested that some physicians go beyond expli-
cit, objective assessments and use more intuitive judg-
ments and decisions about appropriateness of opioids.
Multiple physicians’ described how their impressions of
patients’ trustworthiness, based on their accumulated
experience over time, increased their willingness to pre-
scribe opioids. In contrast, some physicians described
their relative unwillingness to prescribe opioids to pa-
tients for whom they did not have a long-standing rela-
tionship. One physician explained how he trades off his
need for specific information to “check” on patients’
opioid-related risks based on his accumulated trust:
So for people that I don’t trust, I use that outside
information to evaluate whether or not this should be
continued in an ongoing relationship or not. The more
I trust them, based on how much I know them, the less
likely I am to sort of do drug tests on them or do kind
of checks on them in some way (Physician 6).
The same physician described how for some of his
most trusted patients who are taking chronic opioids, he
formally documents his trust in their medical record, so
that they won’t be judged negatively by other clinicians:
With me, because I know so many details about them and
I know their kids and know what’s going on in their life. I
know their day-to-day affairs, I’m not worried like they
[other clinicians] are when they go into the hospital and
they only see the medication list. I had a patient where
that was the case here recently. So I kind of documented
some of my trust and my history with that patient on the
chart when they went into the hospital …. (Physician 6)
Other decision making challenges related to opioids
Physicians described a number of other serious decision
making challenges associated with prescribing opioids in
the context of chronic noncancer pain.
Weighing potential therapeutic benefits against opioid risks
Physicians reported struggles in weighing potential the-
rapeutic benefits of opioids versus risks, such as the risks
that patients are being dishonest about their pain and/or
are at risk of abusing, misusing, or diverting opioids. Some
physicians described risks of side effects and adverse events,
but physicians more often emphasized risk of misuse, abuse,
and diversion. One physician categorized his patients,
saying:
You have the patients who definitely need the
medications. You have the patients who definitely
don’t need the medications. Then you have the really
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are difficult to assess whether or not they truly do need
the medication (Physician 12).
The same physician admitted that despite his confi-
dence, he knows he has misjudged patients’:
I would say the vast majority of people I think I get a
good feel for it. But I’ve been snagged so many times
[laughs]. I could have sworn this person was being
straight with me [in reporting their pain]. … I would
imagine you’re not 100 percent right all the time. …
So sometimes you’re probably erring in … not giving
somebody pain medications when they truly do need
it. And you’re gonna err sometimes in giving patients
medications when they don’t need it. (Physician 12)
Another physician described a patient who received
opioids and was using cocaine:
I did a couple of urine screens and things like that. I
was a little uncomfortable, but she was a patient for a
long time. It seemed to keep her out of the emergency
room. If I didn’t give her pain medicine, she’d end up
in the emergency room. Anyway, just recently I found
out that she came into the hospital and she was
positive for cocaine a couple of times. I was like, oh.
You know, sometimes I don’t know how to manage
them effectively …. (Physician 1)
In addition to wanting to keep the patient out of the
emergency room, this physician suggested she prescribed
opioids because of her long-term relationship and desire
to trust the patient, saying: “I mean she's been my patient
a really long time. We've kind of been through a lot of
things together (Physician 1).
In contrast, another physician said her struggles to
judge opioid risks have led her to avoid prescribing opi-
oids altogether:
There’s this sense of, you feel like you’ve been taken
advantage of, and you were out there trying to help
them, and instead, they’re abusing the medication. In
a way, you’re either harming them or harming
someone else out in the community, and so, there is
that feeling of, you don’t wanna be one of those docs.
… It’s kind of like, you get bit several times, and then,
you’re like, ‘I’m just not gonna give pain meds to
anybody.’ (Physician 15)
Time and resource constraints
Physicians also said that time and other resource con-
straints impede their ability to manage chronic opioids
effectively. For example, one physician said:The university has increased the number of patients
you are required to see ever since I’ve been here. …
It’s racing from one patient to another, and sitting
down and doing formal assessments is hard to work
in. … but formal assessment scales and these
lengthy conversations that you would think family
practitioners would sit down and spend all this time,
this practice isn’t set up to do that. It’s set up to move
35,000 patient visits through a year (Physician 11).
Similarly, a VA physician described how managing
other chronic conditions can crowd out time to effect-
ively manage pain and opioids: “you’re given a 30-minute
appointment at the VA, and you’ve got a lot to document,
and you got to see about their diabetes and their hyperten-
sion, and their lipids, and all this other stuff. Pain really
never, it’s sort of a labor intensive thing treating pain, so it
takes time” (Physician 10). In addition to time, some
physicians perceived a need for resources such as secure
urine drug screening processes and access to other spe-
cialists, saying, for example:
I find that hard because our office isn’t really set up
for that [urine drug screens]. I really don’t know about
the security. … Occasionally, I’ll do a random one, but
I know I should do them more, but I don’t. It’s just too
complicated. … They’ve [patients who have gone to
pain specialty clinics] described to me the process; that
there’s someone monitoring their urine when they come
out of the bathroom or something. That’s not true of
our clinic, we’re not set up that way. Then I think,
well, should I even bother? (Physician 1)
The role of primary care specialties in managing pain
Physicians offered multiple perspectives on their prepared-
ness to manage chronic opioid therapy and on the role of
primary care in chronic pain. For example, a family and an
internal medicine physician each described how, over
time, they began to specialize in pain care. As one said:
Because the thing is we are—family is so broad that
people can specialize in all type of stuff and still be
called a family physician. It’s accordin' to what your
interests lie. My interests started with chronic pain
management because of my previous jobs (Physician 14).
She further described how an increasing volume of pa-
tients with chronic pain led her to enroll in pain-related
continuing education to learn about alternatives to opi-
oids: “I felt like, ”okay, this cannot be good medicine. I’m
sittin’ here writin’ 20 pills. I have got to find a better way
to do this.“ At that point that’s when now all my CMEs
are goin’ this way” (Physician 14). Similarly, one of the
internal medicine physicians from the VA described how
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“specialize” in pain:
It’s [pain] been, it’s become an interest of mine in the
last four or five years. I did none in private practice.
Then when I came back here [the VA] and inherited a
practice with just, probably, I think as much as 20
percent of primary care is on opioids, so you come into
this system and all of a sudden you see all these
people on high dose, long acting medicines with very
little risk assessment, very little monitoring, very little
safety stuff that you normally have in place to make
sure the drugs were being used safely. (Physician 10)
In contrast, other physicians described how they ac-
tively avoid patients with complex chronic pain condi-
tions and/or on chronic opioids therapy. For example,
one said: “I guess when you’re in primary care you can
choose. It’s not like you’re specializing but some of the
docs decide to go ahead and do more pain management
so I guess I didn’t go that route” (Physician 5). Altogether,
physicians described varying levels of interest in caring
for chronic pain and willingness to prescribe chronic
opioids.
Discussion
Physicians in our U.S.-based study described a range of
decision making challenges, including uncertainty in
diagnosing chronic non-cancer pain conditions, discom-
fort assessing opioid-related risks and benefits, a lack of
time and resources to provide pain care, and trouble es-
tablishing trust in patients. As a product of these chal-
lenges, our study indicates that some primary care
physicians actively avoid caring for chronic noncancer
pain. Given the enormous prevalence of chronic pain
relative to pain specialist physicians in the U.S. [1], this
finding raises serious concerns about patients’ access to
effective chronic noncancer pain care.
Our study also provides insight into how some pri-
mary care physicians’ judgments are likely molded by
perceptions of insufficient training, misinformation, con-
flicting information, high uncertainty, frustration, and
mistrust when managing chronic opioids for pain.
Others have described such clinical scenarios as “infor-
mation chaos,” which may harm physician performance
and patient safety [32]. Thus, our findings suggest the
potential value of electronic health record (EHR)-based
decision support that fosters clinical team-based ap-
proaches to information management [32] that ensure
physicians are able to diagnosis pain conditions, weigh
opioid risks and benefits, and judge patient trustworthi-
ness more objectively. For example, decision support
that collects and communicates individualized informa-
tion on the etiology and classification of patients’ pain oron medication options could help physicians more con-
fidently and accurately deliver evidence-based care.
Similarly, decision support could automatically calculate
patients’ risk of opioid abuse and display results to a phys-
ician in the context of opioids’ expected benefit relative to
other treatments. However, such efforts to improve physi-
cians’ decisions must be based on established medical evi-
dence and carefully integrated into clinical interactions so
not to adversely affect workflows or physician-patient
communication and trust [33,34]. Indeed, a prior attempt
to implement guideline-based decision support for chronic
opioid therapy was harmed by clinician time constraints,
competing priorities, and discomfort communicating with
patients about opioids [15].
To complement decision support, our study also sug-
gests the need for education and policies that support
high quality primary care for chronic noncancer pain.
Like prior work in an inpatient setting [35], our study
clearly showed that some physicians mistrust their pa-
tients’ self-reported pain and desire objective measures,
such as imaging results indicating musculoskeletal path-
ology. But, this may reflect a basic lack of understanding
that many pain conditions, such as centralized pain, can-
not be assessed with routine physical exam or standard
X-Ray, MRI, or CT imaging techniques [36]. Consistent
with the literature ([37,38], we also found that physicians
often rely on tacit assessments of patients’ risk of aberrant
drug-related behaviors, such as opioid abuse, despite rec-
ognizing they may make inaccurate assessments. There-
fore, clinical leaders, educators and policymakers must
continue to create and disseminate usable, evidence-based
education on chronic pain and opioid risk assessment. In
particular, educators should aim to correct judgments that
“legitimate” pain is always observable in objective informa-
tion, that “pain care” is equivalent to prescribing opioids,
or that risk of aberrant drug-related behaviors is easily
intuited. In broad terms, it must be acknowledge that
patients with chronic pain conditions can be time-
consuming and emotionally tiring to treat [39], but pain,
like diabetes or hypertension, can be effectively treated in
primary care settings [40].
This study has some limitations. First, we aimed to ob-
tain rich information from a small, diverse sample of
physicians in one U.S. state. As a consequence, our re-
sults do not allow us to make general or representative
conclusions about physician populations. However, our
sampling strategy was successful in recruiting physicians
who varied in terms of age, gender, practice location,
practice ownership, and experience and training in pain
care. Yet, it is possible that our sampling did not capture
some physician decision making approaches, such as
those that vary across cultures or larger international
boundaries. Therefore, we would be cautious in ascrib-
ing transferability of our results to international settings.
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flect predispositions or other biases of the data analysts
rather than purely reflecting the phenomenon being
studied. To mitigate these risks, we used multiple data
analysts. And, each analyst wrote reflective memos dur-
ing the analysis to help verify their processes and ensure
that emergent themes reflected the study data rather
than internal biases. Finally, our data reflect physicians’
perceptions of how they make decisions, which may re-
flect their sensemaking process, social desirability, or ac-
tual decision making [41-43]. While we did not observe
actual physician behavior, we did ask numerous follow-
up questions to probe beyond potentially rehearsed re-
sponses. Encouragingly, physicians reported a range of
decision making strategies and admitted that their deci-
sions sometimes led to poor outcomes. Therefore, we
believe that our results are reasonably reflective of actual
decision making processes.
Conclusions
This study contributes new insights into decision making
challenges that primary care physicians face in managing
the many patients with chronic noncancer pain. In par-
ticular, we identified and richly described physicians’ strug-
gles to deliver high quality care as they seek and make
decisions based on an array of incomplete, conflicting, and
often untrusted information about their patients. Future
work should develop and disseminate decision support
and education that corrects misconceptions about chronic
pain assessment and opioid management while also pro-
viding usable point-of-care information that meaningfully
aids physician-patient interactions.
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